Form 8-K - Current report:
SEC Accession No. 0001558370-23-000173
Filing Date
2023-01-10
Accepted
2023-01-10 07:05:31
Documents
12
Period of Report
2023-01-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K kala-20230109x8k.htm   iXBRL 8-K 32067
  Complete submission text file 0001558370-23-000173.txt   147630

Data Files

Seq Description Document Type Size
2 EX-101.SCH kala-20230109.xsd EX-101.SCH 3128
3 EX-101.LAB kala-20230109_lab.xml EX-101.LAB 15268
4 EX-101.PRE kala-20230109_pre.xml EX-101.PRE 9660
6 EXTRACTED XBRL INSTANCE DOCUMENT kala-20230109x8k_htm.xml XML 4642
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 23519674
SIC: 2834 Pharmaceutical Preparations